13F HOLDINGS REPORT
REGENERON PHARMACEUTICALS, INC.
Quarter ended Q4 2025 · Filed February 6, 2026 · Accession 0001104659-26-011601
Total Value
$33.8M
Positions
2
Other Managers
0
Confidential Omitted
No
Holdings (2)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Intellia Therapeutics, Inc. | NTLA | 3,702,995 | $33.3M | 98.49% |
| 2 | Adicet Bio, Inc. | ACET | 60,511 | $509,503 | 1.51% |